United States Biotechnology & Medical Research

Revolution Medicines Inc (RVMD)

Track

Over the past 90 days, Revolution Medicines Inc. insiders have executed 41 transactions, all of which were sales totaling approximately $48.6 million. Notable activity includes planned and proposed sales by Director Sushil Patel and CFO Jack Anders. These transactions occur as the stock trades near its 52-week high following a 29.7% increase over the last quarter.
Ticker: RVMD Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Revolution Medicines Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 29 Jun 2026
Value US$1,235,290.79 | Price 51.77 | Shares 61,680 (-43.3%)
Planned sale 29 Jun 2026
Value US$944,039.04 | Price 383.10 | Shares 93,509 (+14.1%)
Planned sale 29 Jun 2026
Value US$114,327.00 | Price 190.55 | Shares 600 (-2.5%)
Planned sale 29 Jun 2026
Value US$18,857.00 | Price 188.57 | Shares 100 (-0.4%)
Planned sale 29 Jun 2026
Value US$56,348.01 | Price 187.83 | Shares 300 (-1.2%)
Planned sale 29 Jun 2026
Value US$160,373.67 | Price 186.92 | Shares 858 (-3.4%)
Planned sale 29 Jun 2026
Value US$204,489.01 | Price 185.90 | Shares 1,100 (-4.2%)
Planned sale 29 Jun 2026
Value US$166,128.21 | Price 184.59 | Shares 900 (-3.3%)
Planned sale 29 Jun 2026
Value US$54,951.99 | Price 183.17 | Shares 300 (-1.1%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-01 2026-06-29 PlS Planned sale
1.8
Patel Sushil
Non-Executive Director
61,680 -43.3%
51.77
US$1,235,291 		61,680 -43.3% 51.77 US$1,235,291
2026-07-01 2026-06-29 PlS Planned sale
1.8
Patel Sushil
Non-Executive Director
93,509 +14.1%
383.10
US$944,039 		93,509 +14.1% 383.10 US$944,039
2026-07-01 2026-06-29 PlS Planned sale
1.8
Patel Sushil
Non-Executive Director
20,352 -13.6%
340.04
US$481,946 		20,352 -13.6% 340.04 US$481,946
2026-07-01 2026-06-29 PlS Planned sale
1.8
Patel Sushil
Non-Executive Director
100 -0.4%
188.57
US$18,857 		100 -0.4% 188.57 US$18,857
2026-07-01 2026-06-29 PlS Planned sale
1.8
Patel Sushil
Non-Executive Director
300 -1.2%
187.83
US$56,348 		300 -1.2% 187.83 US$56,348
2026-07-01 2026-06-29 PlS Planned sale
1.8
Patel Sushil
Non-Executive Director
858 -3.4%
186.92
US$160,374 		858 -3.4% 186.92 US$160,374
2026-07-01 2026-06-29 PlS Planned sale
1.8
Patel Sushil
Non-Executive Director
1,100 -4.2%
185.90
US$204,489 		1,100 -4.2% 185.90 US$204,489
2026-07-01 2026-06-29 PlS Planned sale
1.8
Patel Sushil
Non-Executive Director
900 -3.3%
184.59
US$166,128 		900 -3.3% 184.59 US$166,128
2026-07-01 2026-06-29 PlS Planned sale
1.8
Patel Sushil
Non-Executive Director
300 -1.1%
183.17
US$54,952 		300 -1.1% 183.17 US$54,952
2026-06-29 2026-06-29 PrS Proposed sale
1.8
SUSHIL PATEL

Director

Non-Executive Director
5,580
182.08
US$1,016,006 		5,580 182.08 US$1,016,006
2026-06-26 2026-06-24 PlS Planned sale
2.9
Anders Jack

Chief Financial Officer

Officer
300 -0.2%
170.32
US$51,096 		300 -0.2% 170.32 US$51,096
2026-06-26 2026-06-24 PlS Planned sale
2.9
Anders Jack

Chief Financial Officer

Officer
5,651 -4.4%
169.24
US$956,398 		5,651 -4.4% 169.24 US$956,398
2026-06-26 2026-06-24 PlS Planned sale
2.9
Anders Jack

Chief Financial Officer

Officer
9,496 -6.8%
168.20
US$1,597,188 		9,496 -6.8% 168.20 US$1,597,188
2026-06-26 2026-06-24 PlS Planned sale
2.9
Anders Jack

Chief Financial Officer

Officer
4,553 -3.2%
167.35
US$761,922 		4,553 -3.2% 167.35 US$761,922
2026-06-24 2026-06-24 PrS Proposed sale
2.9
JACK ANDERS

Officer

Officer
20,000
169.51
US$3,390,200 		20,000 169.51 US$3,390,200
2026-06-17 2026-06-17 PlS Planned sale
3.0
Horn Margaret A

Chief Operating Officer

Officer
29,600 -16.1%
160.12
US$4,739,679 		29,600 -16.1% 160.12 US$4,739,679
2026-06-18 2026-06-16 PlS Planned sale
2.9
Cislini Jeff

General Counsel

Officer
2,157 -3.7%
156.12
US$336,749 		2,157 -3.7% 156.12 US$336,749
2026-06-18 2026-06-16 PlS Planned sale
Mancini Anthony

See Remarks

Officer
4,615 -8.5%
156.12
US$720,490 		4,615 -8.5% 156.12 US$720,490
2026-06-18 2026-06-16 PlS Planned sale
2.2
GOLDSMITH MARK A

See Remarks

Executive Director
10,020 -3.6%
156.12
US$1,564,310 		10,020 -3.6% 156.12 US$1,564,310
2026-06-18 2026-06-16 PlS Planned sale
2.9
Kelsey Stephen Michael

See Remarks

Officer
4,175 -1.4%
156.12
US$651,798 		4,175 -1.4% 156.12 US$651,798
2026-06-18 2026-06-16 PlS Planned sale
2.9
Anders Jack

Chief Financial Officer

Officer
2,722 -2.2%
156.12
US$424,956 		2,722 -2.2% 156.12 US$424,956
2026-06-17 2026-06-15 PlS Planned sale
3.0
Horn Margaret A

Chief Operating Officer

Officer
60,400 -27.6%
160.17
US$9,674,304 		60,400 -27.6% 160.17 US$9,674,304
2026-06-15 2026-06-15 PrS Proposed sale
2.2
GOLDSMITH MARK A

Officer; Director

Executive Director
9,772
153.87
US$1,503,618 		9,772 153.87 US$1,503,618
2026-06-15 2026-06-15 PrS Proposed sale
2.9
Cislini Jeff

Officer

Officer
1,656
153.87
US$254,809 		1,656 153.87 US$254,809
2026-06-15 2026-06-15 PrS Proposed sale
2.9
Anders Jack

Officer

Officer
2,653
153.87
US$408,217 		2,653 153.87 US$408,217
2026-06-15 2026-06-15 PrS Proposed sale
Mancini Anthony

Officer

Officer
4,211
153.87
US$647,947 		4,211 153.87 US$647,947
2026-06-15 2026-06-15 PrS Proposed sale
2.9
Kelsey Stephen Michael

Officer

Officer
4,071
153.87
US$626,405 		4,071 153.87 US$626,405
2026-06-15 2026-06-15 PrS Proposed sale
3.0
Horn Margaret A

Officer

Officer
3,486
153.87
US$536,391 		3,486 153.87 US$536,391
2026-06-15 2026-06-15 PrS Proposed sale
3.0
MARGARET A HORN

Officer

Officer
90,000
153.87
US$13,848,300 		90,000 153.87 US$13,848,300
2026-06-15 2026-06-11 PlS Planned sale
3.0
Horn Margaret A

Chief Operating Officer

Officer
200 -0.1%
150.17
US$30,034 		200 -0.1% 150.17 US$30,034
2026-06-15 2026-06-11 PlS Planned sale
3.0
Horn Margaret A

Chief Operating Officer

Officer
4,600 -2.8%
149.64
US$688,357 		4,600 -2.8% 149.64 US$688,357
2026-06-15 2026-06-11 PlS Planned sale
3.0
Horn Margaret A

Chief Operating Officer

Officer
1,800 -1.1%
148.72
US$267,702 		1,800 -1.1% 148.72 US$267,702
2026-06-15 2026-06-11 PlS Planned sale
3.0
Horn Margaret A

Chief Operating Officer

Officer
500 -0.3%
147.27
US$73,636 		500 -0.3% 147.27 US$73,636
2026-06-15 2026-06-11 PlS Planned sale
3.0
Horn Margaret A

Chief Operating Officer

Officer
700 -0.4%
146.04
US$102,226 		700 -0.4% 146.04 US$102,226
2026-06-15 2026-06-11 PlS Planned sale
3.0
Horn Margaret A

Chief Operating Officer

Officer
885 -0.5%
145.15
US$128,457 		885 -0.5% 145.15 US$128,457
2026-06-15 2026-06-11 PlS Planned sale
3.0
Horn Margaret A

Chief Operating Officer

Officer
1,315 -0.8%
144.28
US$189,727 		1,315 -0.8% 144.28 US$189,727
2026-06-11 2026-06-11 PrS Proposed sale
3.0
MARGARET A HORN

Officer

Officer
10,000
144.19
US$1,441,900 		10,000 144.19 US$1,441,900
2026-05-28 2026-05-26 PlS Planned sale
Mancini Anthony

See Remarks

Officer
421 -0.8%
154.82
US$65,177 		421 -0.8% 154.82 US$65,177
2026-05-28 2026-05-26 PlS Planned sale
Mancini Anthony

See Remarks

Officer
2,000 -3.5%
154.06
US$308,122 		2,000 -3.5% 154.06 US$308,122
2026-05-28 2026-05-26 PlS Planned sale
Mancini Anthony

See Remarks

Officer
700 -1.2%
153.30
US$107,312 		700 -1.2% 153.30 US$107,312
2026-05-26 2026-05-26 PrS Proposed sale
ANTHONY MANCINI

Officer

Officer
3,121
151.56
US$473,019 		3,121 151.56 US$473,019
2026-04-29 2026-04-27 PlS Planned sale
Mancini Anthony

See Remarks

Officer
400 -0.7%
134.34
US$53,734 		400 -0.7% 134.34 US$53,734
2026-04-29 2026-04-27 PlS Planned sale
Mancini Anthony

See Remarks

Officer
1,049 -1.9%
132.88
US$139,388 		1,049 -1.9% 132.88 US$139,388
2026-04-29 2026-04-27 PlS Planned sale
Mancini Anthony

See Remarks

Officer
1,671 -2.9%
131.66
US$220,007 		1,671 -2.9% 131.66 US$220,007
2026-04-27 2026-04-27 PrS Proposed sale
ANTHONY MANCINI

Officer

Officer
3,120
135.30
US$422,136 		3,120 135.30 US$422,136
2026-04-17 2026-04-15 PlS Planned sale
2.2
GOLDSMITH MARK A

See Remarks

Executive Director
120,000 -30.2%
150.09
US$18,010,488 		120,000 -30.2% 150.09 US$18,010,488
2026-04-15 2026-04-15 PrS Proposed sale
2.2
MARK A GOLDSMITH

Director; Officer

Executive Director
120,000
147.01
US$17,641,200 		120,000 147.01 US$17,641,200
2026-03-26 2026-03-25 PlS Planned sale
Mancini Anthony

See Remarks

Officer
400 -0.7%
97.21
US$38,883 		400 -0.7% 97.21 US$38,883
2026-03-26 2026-03-25 PlS Planned sale
Mancini Anthony

See Remarks

Officer
11,036 -16.8%
96.43
US$1,064,200 		11,036 -16.8% 96.43 US$1,064,200
2026-03-26 2026-03-25 PlS Planned sale
Mancini Anthony

See Remarks

Officer
21,086 -24.3%
95.49
US$2,013,416 		21,086 -24.3% 95.49 US$2,013,416
2026-03-26 2026-03-25 PlS Planned sale
Mancini Anthony

See Remarks

Officer
3,128 -3.5%
94.16
US$294,520 		3,128 -3.5% 94.16 US$294,520
2026-03-26 2026-03-25 PlS Planned sale
Mancini Anthony

See Remarks

Officer
1,800 -2.0%
93.22
US$167,801 		1,800 -2.0% 93.22 US$167,801
2026-03-26 2026-03-25 PrS Proposed sale
Mancini Anthony

Officer

Officer
37,450
95.56
US$3,578,823 		37,450 95.56 US$3,578,823
2026-03-19 2026-03-19 PlS Planned sale
2.9
Cislini Jeff

General Counsel

Officer
1,163 -1.9%
97.44
US$113,323 		1,163 -1.9% 97.44 US$113,323
2026-03-19 2026-03-19 PrS Proposed sale
2.9
JEFFREY TODD CISLINI

Officer

Officer
1,163
98.11
US$114,102 		1,163 98.11 US$114,102
2026-03-19 2026-03-17 PlS Planned sale
Wei Lin

Chief Medical Officer

Officer
2,073 -2.0%
99.48
US$206,223 		2,073 -2.0% 99.48 US$206,223
2026-03-19 2026-03-17 PlS Planned sale
2.9
Kelsey Stephen Michael

See Remarks

Officer
4,302 -1.4%
99.48
US$427,965 		4,302 -1.4% 99.48 US$427,965
2026-03-19 2026-03-17 PlS Planned sale
2.2
GOLDSMITH MARK A

See Remarks

Executive Director
12,871 -4.4%
99.48
US$1,280,412 		12,871 -4.4% 99.48 US$1,280,412
2026-03-19 2026-03-17 PlS Planned sale
3.0
Horn Margaret A

Chief Operating Officer

Officer
4,583 -2.8%
99.48
US$455,919 		4,583 -2.8% 99.48 US$455,919
2026-03-19 2026-03-17 PlS Planned sale
2.9
Anders Jack

Chief Financial Officer

Officer
2,753 -2.1%
99.48
US$273,870 		2,753 -2.1% 99.48 US$273,870
2026-03-19 2026-03-17 PlS Planned sale
2.9
Cislini Jeff

General Counsel

Officer
1,795 -2.9%
99.48
US$178,567 		1,795 -2.9% 99.48 US$178,567
2026-03-19 2026-03-17 PlS Planned sale
2.3
Wang Xiaolin

See Remarks

Officer
2,010 -1.7%
99.48
US$199,956 		2,010 -1.7% 99.48 US$199,956
2026-03-13 2026-03-16 PrS Proposed sale
2.3
Wang Xiaolin

Officer

Officer
2,282
99.59
US$227,264 		2,282 99.59 US$227,264
2026-03-13 2026-03-16 PrS Proposed sale
Wei Lin

Officer

Officer
2,288
99.59
US$227,862 		2,288 99.59 US$227,862
2026-03-13 2026-03-16 PrS Proposed sale
2.9
Kelsey Stephen Michael

Officer

Officer
3,901
99.59
US$388,501 		3,901 99.59 US$388,501
2026-03-13 2026-03-16 PrS Proposed sale
3.0
Horn Margaret A

Officer

Officer
4,722
99.59
US$470,264 		4,722 99.59 US$470,264
2026-03-13 2026-03-16 PrS Proposed sale
2.2
GOLDSMITH MARK A

Officer; Director

Executive Director
13,261
99.59
US$1,320,663 		13,261 99.59 US$1,320,663
2026-03-13 2026-03-16 PrS Proposed sale
2.9
Cislini Jeff

Officer

Officer
2,053
99.59
US$204,458 		2,053 99.59 US$204,458
2026-03-13 2026-03-16 PrS Proposed sale
2.9
Anders Jack

Officer

Officer
2,134
99.59
US$212,525 		2,134 99.59 US$212,525
2026-03-03 2026-03-02 S Sale
2.2
GOLDSMITH MARK A

See Remarks

Executive Director
200 -0.3%
102.08
US$20,416 		200 -0.3% 102.08 US$20,416
2026-03-03 2026-03-02 S Sale
2.2
GOLDSMITH MARK A

See Remarks

Executive Director
2,100 -3.1%
101.63
US$213,432 		2,100 -3.1% 101.63 US$213,432
2026-03-03 2026-03-02 S Sale
2.2
GOLDSMITH MARK A

See Remarks

Executive Director
600 -0.9%
100.19
US$60,116 		600 -0.9% 100.19 US$60,116
2026-03-03 2026-03-02 S Sale
2.2
GOLDSMITH MARK A

See Remarks

Executive Director
100 -0.1%
98.29
US$9,829 		100 -0.1% 98.29 US$9,829
2026-03-03 2026-03-02 S Sale
2.2
GOLDSMITH MARK A

See Remarks

Executive Director
800 -1.2%
102.00
US$81,599 		800 -1.2% 102.00 US$81,599
2026-03-03 2026-03-02 S Sale
2.2
GOLDSMITH MARK A

See Remarks

Executive Director
1,700 -2.5%
101.47
US$172,506 		1,700 -2.5% 101.47 US$172,506
Explore more

More insider trading research around Revolution Medicines Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America